First Time Loading...
A

AFT Pharmaceuticals Ltd
NZX:AFT

Watchlist Manager
AFT Pharmaceuticals Ltd
NZX:AFT
Watchlist
Price: 2.9 NZD -2.36% Market Closed
Updated: May 7, 2024

Wall Street
Price Targets

AFT Price Targets Summary
AFT Pharmaceuticals Ltd

Wall Street analysts forecast AFT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFT is 3.77 NZD with a low forecast of 2.83 NZD and a high forecast of 4.83 NZD.

Lowest
Price Target
2.83 NZD
2% Downside
Average
Price Target
3.77 NZD
30% Upside
Highest
Price Target
4.83 NZD
67% Upside
AFT Pharmaceuticals Ltd Competitors:
Price Targets
000919
Jinling Pharmaceutical Co Ltd
25% Upside
NEULANDLAB
Neuland Laboratories Ltd
15% Upside
249420
Il Dong Pharmaceutical Co Ltd
224% Upside
1093
CSPC Pharmaceutical Group Ltd
46% Upside
GRIN
Grown Rogue International Inc
27% Downside
MRK
Merck & Co Inc
12% Upside
293480
Hana Pharm Co Ltd
50% Upside
4578
Otsuka Holdings Co Ltd
3% Downside

Revenue
Forecast

Revenue Estimate
AFT Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 14%. The projected CAGR for the next 3 years is 18%.

14%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AFT Pharmaceuticals Ltd

The compound annual growth rate of AFT Pharmaceuticals Ltd's operating income for the next 3 years is 28%.

N/A
Past Growth
28%
Estimated Growth
Estimates Accuracy
9%
Average Beat

Net Income
Forecast

Net Income Estimate
AFT Pharmaceuticals Ltd

The compound annual growth rate of AFT Pharmaceuticals Ltd's net income for the next 3 years is 31%.

N/A
Past Growth
31%
Estimated Growth
Estimates Accuracy
17%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFT's stock price target?
Price Target
3.77 NZD

According to Wall Street analysts, the average 1-year price target for AFT is 3.77 NZD with a low forecast of 2.83 NZD and a high forecast of 4.83 NZD.

What is AFT Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for AFT Pharmaceuticals Ltd's revenue is 14%. The projected CAGR for the next 3 years is 18%.

What is AFT Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
28%

The compound annual growth rate of AFT Pharmaceuticals Ltd's operating income for the next 3 years is 28%.

What is AFT Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
31%

The compound annual growth rate of AFT Pharmaceuticals Ltd's net income for the next 3 years is 31%.